Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Rapid Cancer Tests Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Rapid Cancer Tests Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Blood Test
1.3.3 Urine Test
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Rapid Cancer Tests Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Rapid Cancer Tests Production Capacity Analysis
2.1.1 Global Rapid Cancer Tests Production Value (2015-2026)
2.1.2 Global Rapid Cancer Tests Production (2015-2026)
2.1.3 Global Rapid Cancer Tests Capacity (2015-2026)
2.1.4 Global Rapid Cancer Tests Marketing Pricing and Trends
2.2 Global Rapid Cancer Tests Market Size Growth Potential by Key Producing Regions
2.2.1 Global Rapid Cancer Tests Market Size by Key Producing Regions: 2015 VS 2021 VS 2026
2.2.2 Global Rapid Cancer Tests Market Share by Key Producing Regions: 2021 VS 2026
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Primary Interviews with Key Rapid Cancer Tests Players: Views for Future
3 Market Share by Manufacturers
3.1 Global Top Manufacturers by Rapid Cancer Tests Production Capacity
3.1.1 Global Top Manufacturers by Rapid Cancer Tests Production Capacity (2015-2020)
3.1.2 Global Top Manufacturers by Rapid Cancer Tests Production (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Rapid Cancer Tests Production in 2019
3.2 Global Top Manufacturers by Rapid Cancer Tests Revenue
3.2.1 Global Top Manufacturers by Rapid Cancer Tests Revenue (2015-2020)
3.2.2 Global Top Manufacturers Market Share by Rapid Cancer Tests Revenue (2015-2020)
3.2.3 Global Rapid Cancer Tests Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rapid Cancer Tests as of 2019)
3.4 Global Rapid Cancer Tests Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Rapid Cancer Tests Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Rapid Cancer Tests Market
3.7 Key Manufacturers Rapid Cancer Tests Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Estimate and Forecast by Type (2015-2026)
4.1 Global Rapid Cancer Tests Historic Market Size by Type (2015-2020)
4.1.2 Global Rapid Cancer Tests Production Market Share by Type (2015-2020)
4.1.3 Global Rapid Cancer Tests Production Value Market Share by Type
4.1.4 Rapid Cancer Tests Average Selling Price (ASP) by Type (2015-2020)
4.2 Global Rapid Cancer Tests Market Size Forecast by Type (2021-2026)
4.2.2 Global Rapid Cancer Tests Production Market Share Forecast by Type (2021-2026)
4.2.3 Global Rapid Cancer Tests Production Value Market Share Forecast by Type
4.2.4 Rapid Cancer Tests Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rapid Cancer Tests Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Rapid Cancer Tests Consumption by Application (2015-2020)
5.2 Global Rapid Cancer Tests Consumption by Application (2021-2026)
6 Production by Regions: Market Fact & Figures
6.1 Global Rapid Cancer Tests Production (History Data) by Regions (2015-2020)
6.2 Global Rapid Cancer Tests Production Value (History Data) by Regions
6.3 North America
6.3.1 North America Rapid Cancer Tests Production Growth Rate (2015-2020)
6.3.2 North America Rapid Cancer Tests Production Value Growth Rate (2015-2020)
6.3.3 Key Players Market Share in North America
6.3.4 North America Rapid Cancer Tests Import & Export (2015-2020)
6.4 Europe
6.4.1 Europe Rapid Cancer Tests Production Growth Rate (2015-2020)
6.4.2 Europe Rapid Cancer Tests Production Value Growth Rate (2015-2020)
6.4.3 Key Players Market Share in Europe
6.4.4 Europe Rapid Cancer Tests Import & Export (2015-2020)
6.5 China
6.5.1 China Rapid Cancer Tests Production Growth Rate (2015-2020)
6.5.2 China Rapid Cancer Tests Production Value Growth Rate (2015-2020)
6.5.3 Key Players Market Share in China
6.5.4 China Rapid Cancer Tests Import & Export (2015-2020)
6.6 Japan
6.6.1 Japan Rapid Cancer Tests Production Growth Rate (2015-2020)
6.6.2 Japan Rapid Cancer Tests Production Value Growth Rate (2015-2020)
6.6.3 Key Players Market Share in Japan
6.6.4 Japan Rapid Cancer Tests Import & Export (2015-2020)
7 Rapid Cancer Tests Consumption by Regions: Market Fact & Figures
7.1 Global Rapid Cancer Tests Consumption (History Data) by Regions (2015-2020)
7.2 Global Top Rapid Cancer Tests Consumers (regions/countries) Ranking and Share of Total Rapid Cancer Tests Consumption in 2015 VS 2019
7.3 North America
7.3.1 North America Rapid Cancer Tests Consumption by Type
7.3.2 North America Rapid Cancer Tests Consumption by Application
7.3.3 North America Rapid Cancer Tests Consumption by Countries
7.3.4 U.S.
7.3.5 Canada
7.4 Europe
7.4.1 Europe Rapid Cancer Tests Consumption by Type
7.4.2 Europe Rapid Cancer Tests Consumption by Application
7.4.3 Europe Rapid Cancer Tests Consumption by Countries
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.5 Asia Pacific
7.5.1 Asia Pacific Rapid Cancer Tests Consumption by Type
7.5.2 Asia Pacific Rapid Cancer Tests Consumption by Application
7.5.3 Asia Pacific Rapid Cancer Tests Consumption by Regions
7.5.4 China
7.5.5 Japan
7.5.6 South Korea
7.5.7 India
7.5.8 Australia
7.5.9 Taiwan
7.5.10 Indonesia
7.5.11 Thailand
7.5.12 Malaysia
7.5.13 Philippines
7.5.14 Vietnam
7.6 Central & South America
7.6.1 Central & South America Rapid Cancer Tests Consumption by Type
7.6.2 Central & South America Rapid Cancer Tests Consumption by Application
7.6.3 Central & South America Rapid Cancer Tests Consumption by Countries
7.6.4 Mexico
7.6.5 Brazil
7.6.6 Argentina
7.7 Middle East and Africa
7.7.1 Middle East and Africa Rapid Cancer Tests Consumption by Type
7.7.2 Middle East and Africa Rapid Cancer Tests Consumption by Application
7.7.3 Central & South America Rapid Cancer Tests Consumption by Countries
7.7.4 Turkey
7.7.5 Saudi Arabia
7.7.6 U.A.E
8 Company Profiles
8.1 Abingdon Health
8.1.1 Abingdon Health Corporation Information
8.1.2 Abingdon Health Business Overview and Total Revenue (2019 VS 2018)
8.1.3 Abingdon Health Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.1.4 Rapid Cancer Tests Products and Services
8.1.5 Abingdon Health SWOT Analysis
8.1.6 Abingdon Health Recent Developments
8.2 Abbott
8.2.1 Abbott Corporation Information
8.2.2 Abbott Business Overview and Total Revenue (2019 VS 2018)
8.2.3 Abbott Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.2.4 Rapid Cancer Tests Products and Services
8.2.5 Abbott SWOT Analysis
8.2.6 Abbott Recent Developments
8.3 Alfa Scientific Designs
8.3.1 Alfa Scientific Designs Corporation Information
8.3.2 Alfa Scientific Designs Business Overview and Total Revenue (2019 VS 2018)
8.3.3 Alfa Scientific Designs Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.3.4 Rapid Cancer Tests Products and Services
8.3.5 Alfa Scientific Designs SWOT Analysis
8.3.6 Alfa Scientific Designs Recent Developments
8.4 NanoEntek
8.4.1 NanoEntek Corporation Information
8.4.2 NanoEntek Business Overview and Total Revenue (2019 VS 2018)
8.4.3 NanoEntek Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.4.4 Rapid Cancer Tests Products and Services
8.4.5 NanoEntek SWOT Analysis
8.4.6 NanoEntek Recent Developments
8.5 Biomerica
8.5.1 Biomerica Corporation Information
8.5.2 Biomerica Business Overview and Total Revenue (2019 VS 2018)
8.5.3 Biomerica Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.5.4 Rapid Cancer Tests Products and Services
8.5.5 Biomerica SWOT Analysis
8.5.6 Biomerica Recent Developments
8.6 Biosynex
8.6.1 Biosynex Corporation Information
8.6.2 Biosynex Business Overview and Total Revenue (2019 VS 2018)
8.6.3 Biosynex Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.6.4 Rapid Cancer Tests Products and Services
8.6.5 Biosynex SWOT Analysis
8.6.6 Biosynex Recent Developments
8.7 IDL Biotech
8.7.1 IDL Biotech Corporation Information
8.7.2 IDL Biotech Business Overview and Total Revenue (2019 VS 2018)
8.7.3 IDL Biotech Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.7.4 Rapid Cancer Tests Products and Services
8.7.5 IDL Biotech SWOT Analysis
8.7.6 IDL Biotech Recent Developments
8.8 Exact Sciences
8.8.1 Exact Sciences Corporation Information
8.8.2 Exact Sciences Business Overview and Total Revenue (2019 VS 2018)
8.8.3 Exact Sciences Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.8.4 Rapid Cancer Tests Products and Services
8.8.5 Exact Sciences SWOT Analysis
8.8.6 Exact Sciences Recent Developments
8.9 Firstep Bioresearch
8.9.1 Firstep Bioresearch Corporation Information
8.9.2 Firstep Bioresearch Business Overview and Total Revenue (2019 VS 2018)
8.9.3 Firstep Bioresearch Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.9.4 Rapid Cancer Tests Products and Services
8.9.5 Firstep Bioresearch SWOT Analysis
8.9.6 Firstep Bioresearch Recent Developments
8.10 Hologic
8.10.1 Hologic Corporation Information
8.10.2 Hologic Business Overview and Total Revenue (2019 VS 2018)
8.10.3 Hologic Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.10.4 Rapid Cancer Tests Products and Services
8.10.5 Hologic SWOT Analysis
8.10.6 Hologic Recent Developments
8.11 LifeAssays
8.11.1 LifeAssays Corporation Information
8.11.2 LifeAssays Business Overview and Total Revenue (2019 VS 2018)
8.11.3 LifeAssays Rapid Cancer Tests Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.11.4 Rapid Cancer Tests Products and Services
8.11.5 LifeAssays SWOT Analysis
8.11.6 LifeAssays Recent Developments
9 Rapid Cancer Tests Production Side by Producing Regions (Countries)
9.1 Global Rapid Cancer Tests Production Value Forecast by Region (2021-2026)
9.2 Rapid Cancer Tests Production Forecast by Regions
9.3 Key Rapid Cancer Tests Producing Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Rapid Cancer Tests Consumption Forecast by Top Consumers (Regions/Countries)
10.1 Global Rapid Cancer Tests Consumption Forecast by Region (2021-2026)
10.2 North America Market Consumption YoY Growth Forecast
10.2.1 North America Rapid Cancer Tests Consumption YoY Growth (2021-2026)
10.2.2 North America Rapid Cancer Tests Consumption Forecast by Country (2021-2026)
10.3 Europe Market Consumption YoY Growth Forecast
10.3.1 Europe Rapid Cancer Tests Consumption YoY Growth (2021-2026)
10.3.2 Europe Rapid Cancer Tests Consumption Forecast by Country (2021-2026)
10.4 Asia Pacific Market Consumption YoY Growth Forecast
10.4.1 Asia Pacific Rapid Cancer Tests Consumption YoY Growth (2021-2026)
10.4.1 Asia Pacific Rapid Cancer Tests Consumption Forecast by Regions (2021-2026)
10.5 Latin America Market Consumption YoY Growth Forecast
10.5.1 Latin America Rapid Cancer Tests Consumption YoY Growth (2021-2026)
10.5.2 Latin America Rapid Cancer Tests Consumption Forecast by Country (2021-2026)
10.6 Middle East and Africa Market Consumption YoY Growth Forecast
10.6.1 Middle East and Africa Rapid Cancer Tests Consumption YoY Growth (2021-2026)
10.6.2 Middle East and Africa Rapid Cancer Tests Consumption Forecast by Country (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Rapid Cancer Tests Sales Channels
11.2.2 Rapid Cancer Tests Distributors
11.3 Rapid Cancer Tests Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
【掲載企業】
Abingdon Health、Abbott、Alfa Scientific Designs、NanoEntek、Biomerica、Biosynex、IDL Biotech、Exact Sciences、Firstep Bioresearch、Hologic、LifeAssays
【免責事項】
https://www.globalresearch.jp/disclaimer